Nonalcoholic fatty liver disease burden – Switzerland 2018–2030

Nonalcoholic fatty liver disease burden – Switzerland 2018–2030

As a result of epidemic levels of obesity and diabetes mellitus, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) will contribute to increases in the liver-related disease burden in Switzerland. A Markov model was built to quantify fibrosis progression amo...

Full description

Bibliographic Details
Main Authors: Nicolas Goossens, Stefano Bellentani, Andreas Cerny, Jean-Francois Dufour, François R. Jornayvaz, Joachim Mertens, Alberto Moriggia, Beat Muellhaupt, Francesco Negro, Homie Razavi, David Semela, Chris Estes
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2019-12-01
Series:Swiss Medical Weekly
Subjects:
metabolic syndrome
non-alcoholic fatty liver disease
liver cirrhosis
liver neoplasms
Online Access:https://www.smw.ch/index.php/smw/article/view/2703

Similar Items

Similar Items